Corient Private Wealth LLC boosted its position in Nutrien Ltd. (NYSE:NTR - Free Report) by 22.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,254 shares of the company's stock after buying an additional 6,027 shares during the quarter. Corient Private Wealth LLC's holdings in Nutrien were worth $1,489,000 as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. Uncommon Cents Investing LLC grew its holdings in shares of Nutrien by 2.1% in the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company's stock valued at $517,000 after acquiring an additional 235 shares in the last quarter. Rhumbline Advisers grew its stake in Nutrien by 3.5% in the fourth quarter. Rhumbline Advisers now owns 7,398 shares of the company's stock valued at $331,000 after purchasing an additional 247 shares in the last quarter. FFT Wealth Management LLC increased its position in shares of Nutrien by 0.9% during the 4th quarter. FFT Wealth Management LLC now owns 29,732 shares of the company's stock worth $1,330,000 after purchasing an additional 277 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Nutrien by 23.9% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,804 shares of the company's stock worth $81,000 after purchasing an additional 348 shares during the last quarter. Finally, Kingsview Wealth Management LLC raised its stake in shares of Nutrien by 3.3% during the 3rd quarter. Kingsview Wealth Management LLC now owns 11,317 shares of the company's stock worth $544,000 after purchasing an additional 365 shares in the last quarter. Institutional investors own 63.10% of the company's stock.
Nutrien Stock Performance
Shares of NTR traded down $0.63 during mid-day trading on Friday, hitting $50.27. 358,788 shares of the company's stock were exchanged, compared to its average volume of 2,029,567. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The firm has a market cap of $24.59 billion, a price-to-earnings ratio of 36.68, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81. The stock's 50-day simple moving average is $51.62 and its 200-day simple moving average is $48.94. Nutrien Ltd. has a 52 week low of $43.70 and a 52 week high of $60.87.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. On average, equities research analysts expect that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Cuts Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.18 annualized dividend and a dividend yield of 4.34%. Nutrien's dividend payout ratio is currently 159.12%.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on NTR. Mizuho raised their target price on shares of Nutrien from $52.00 to $55.00 and gave the company a "neutral" rating in a research note on Thursday, February 20th. Royal Bank of Canada reissued an "outperform" rating and issued a $60.00 price objective on shares of Nutrien in a research report on Monday, February 24th. Wells Fargo & Company upped their target price on shares of Nutrien from $53.00 to $56.00 and gave the company an "equal weight" rating in a report on Friday, February 21st. Piper Sandler upped their price objective on Nutrien from $58.00 to $63.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. Finally, Scotiabank raised their price objective on Nutrien from $60.00 to $62.00 and gave the company a "sector outperform" rating in a research report on Monday, February 24th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $60.00.
Get Our Latest Stock Analysis on NTR
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Read More
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
